Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Omegaven™
DRUG
3 trials
Sponsors
University of Nebraska
, Children's Hospital Los Angeles
, University of Zurich
Conditions
Cholestasis
Liver Injury
Major Liver Surgery
Parenteral Nutrition Associated Liver Disease PNALD
Phase 2
Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis
Completed
NCT00826020
University of Nebraska
Cholestasis, Parenteral Nutrition Associated Liver Disease PNALD
Start: 2009-05-01
End: 2017-10-06
Updated: 2023-10-05
Phase 3
Effects of Omega-3 Fatty Acids on Outcome After Major Liver Resection
NCT01884948
University of Zurich
Major Liver Surgery
Start: 2013-07-31
End: 2016-03-31
Target: 258
Updated: 2014-06-04
Unknown Phase
Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury
Completed
NCT01089426
Children's Hospital Los Angeles
Liver Injury
Start: 2008-09-30
End: 2019-04-30
Updated: 2019-05-06
Related Papers
Perioperative omega-3 fatty acids fail to confer protection in liver surgery: Results of a multicentric, double-blind, randomized controlled trial.
2019-10-15
17 citations
"A randomized, double-blind study of the effects of omega-3 fatty acids (Omegaven) on outcome after major liver resection".
2015-08-14
17 citations